Table 4.
N° of vaccine doses | |||||||||
---|---|---|---|---|---|---|---|---|---|
Age | n (%) | 0 | 1 | 2 | 3 | 4 | 5 | NDb | |
Cases | 0–<6 m | 84 (10) | 43 | 19 | 6 | - | - | - | 16 |
6–<12 m | 13 (1.55) | 2 | - | 8 | - | - | - | 3 | |
1–<2 y | 5 (0.6) | 1 | 2 | 1 | - | - | - | 1 | |
2–<4 y | 9 (1.07) | - | 3 | - | - | 3 | - | 3 | |
4–<6 y | 7 (0.83) | - | 2 | - | - | 3 | - | 2 | |
6–< 10 y | 31 (3.69) | 4 | 10 | 1 | 4 | 2 | - | 10 | |
10–<15 y | 18 (2.14) | 1 | 10 | - | 2 | - | - | 5 | |
15–<20 y | 6 (0.71) | 3 | 2 | - | - | - | - | 1 | |
20–<30 y | 8 (0.95) | 1 | 2 | - | - | - | - | 5 | |
30–<40 y | 6 (0.71) | 3 | 2 | - | - | - | - | 1 | |
>40 y | 4 (0.48) | 1 | - | - | - | - | - | 3 | |
Non-cases | 0–<6 m | 150 (17.86) | 82 | 21 | 6 | 3 | 38 | ||
6–<12 m | 54 (6.43) | 15 | 1 | 11 | 17 | - | - | 10 | |
1–<2 y | 54 (6.43) | 5 | 1 | 2 | 15 | 10 | - | 21 | |
2–<4 y | 60 (7.14) | 2 | 6 | 6 | 1 | 27 | 3 | 15 | |
4–<6 y | 64 (7.62) | 6 | 2 | 1 | 5 | 19 | 22 | 9 | |
6–< 10 y | 91 (10.83) | 11 | 1 | 3 | 23 | 25 | 4 | 24 | |
10–<15 y | 48 (5.71) | 14 | 1 | 6 | 12 | 2 | - | 13 | |
15–<20 y | 13 (1.55) | 3 | - | - | - | 1 | - | 9 | |
20–<30 y | 49 (5.83) | 15 | - | - | 2 | 1 | - | 31 | |
30–<40 y | 36 (4.29) | 16 | - | - | 1 | 1 | - | 18 | |
>40 y | 23 (2.74) | 10 | - | - | - | 1 | - | 12 | |
No data of age | 7 (0.83) | 3 | 1 | - | - | - | - | 3 | |
Total | 840 (100) | 241 | 86 | 51 | 85 | 95 | 29 | 253 |
aPentavalent vaccine for 1–3 doses plus DTwP for 4–5 booster doses
b ND no data available from vaccine records